OpenVSafe by OpenVAERS
Search V-safe

N7Q-44898-87365

2 vaccinations 3 coded responses 8 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
060 / CT
Registered
2021-03-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-20
    Registered in v-safe
  3. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  4. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-08
    Dose 2 — Pfizer-BioNTech
  6. 2021-04-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Migraine — Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activities
    Free text: Migraine, onset about 12 hours after vaccination
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  8. 2021-04-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Migraine — Feeling: Fair · Headache
    Free text: Migraine (relieved with current prescription medication)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-17
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  10. 2021-04-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2022-04-08
    Survey response — 12 months, dose 2
    MedDRA: Anxiety, Paraesthesia, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Worsening anxiety, intermittent pins and needles sensation, tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-04-08
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  13. 2022-04-14
  14. 2022-04-19

Vaccinations

DoseDateManufacturerCo-administered
12021-03-18Pfizer-BioNTech
22021-04-08Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-10

Systemic reaction (other): Migraine, onset about 12 hours after vaccination

2021-04-12

Systemic reaction (other): Migraine (relieved with current prescription medication)

Release 11 — 12 months, dose 2

2022-04-08

Symptoms: Worsening anxiety, intermittent pins and needles sensation, tinnitus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety · · ✓
SDParaesthesia · · ✓
SDTinnitus · · ✓
SROMigraine ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release